Comprehensive Analysis of the Small Business Set-Aside and Statutory Framework of the Maryland Research and Development Tax Credit

The Small Business Set-Aside is a reserved $3.5 million portion of Maryland’s $12 million annual R&D tax credit fund, specifically protected for companies with under $5 million in net book value assets. This allocation ensures smaller firms receive meaningful, refundable cash incentives even when the program is heavily oversubscribed by larger corporations, effectively insulating innovation-focused startups from competitive exhaustion of the state’s fiscal caps.

The implementation of this set-aside represents a strategic pivot in Maryland’s economic development philosophy, moving away from a generalized incentive structure toward a targeted mechanism that prioritizes liquidity for early-stage ventures. Historically, the Maryland Research and Development (R&D) tax credit program, while successful in aggregate, suffered from a structural imbalance where large-scale multinational corporations captured the vast majority of certified credits, often leaving smaller, high-growth startups with negligible awards due to severe proration.1 By carving out a specific “portion of the cap,” the Maryland General Assembly has codified a fiscal priority: that the state’s most agile and capital-constrained innovators must have a guaranteed pool of resources to sustain long-term research trajectories. This analysis explores the legal, fiscal, and administrative nuances of the set-aside, providing a granular view of how Tax-General § 10-721 functions in practice for the state’s burgeoning technology and life sciences sectors.

Statutory Evolution and the Legislative Intent of Section 10-721

The Research and Development Tax Credit Program, established in 2000 and codified under Maryland Tax-General § 10-721, was originally designed as a broad incentive for all businesses conducting qualified research in the state.2 However, the efficacy of the program for smaller entities was significantly hindered by its original architecture, which included a “Basic” credit and a “Growth” credit.4 The Basic credit awarded 3% of expenses up to a base amount, while the Growth credit awarded 10% on expenses exceeding that base.4 Because the program was consistently oversubscribed, proration often reduced the effective value of these credits to fractions of a percent, sometimes resulting in awards as low as one dollar for certain applicants.1

To rectify these deficiencies, the Maryland Department of Commerce championed Senate Bill 196 (SB 196), which was signed into law in 2021.1 This legislation enacted a comprehensive overhaul of the program, extending its termination date to June 30, 2027, and introducing the current $12 million consolidated Growth credit model.7 The most transformative aspect of this overhaul was the creation of the $3.5 million Small Business Set-Aside, a direct response to data from the Department of Legislative Services indicating that while small businesses accounted for roughly one-third of the applicants, they received only about 2% of total certified credits under the old system.1

The current statutory language explicitly states that the Department of Commerce “shall reserve $3,500,000 of the credits authorized” specifically for small businesses.9 This mandatory reservation creates a bifurcated application pool, where small businesses compete only against other small businesses for their portion of the cap, rather than being diluted by the multi-million dollar R&D budgets of large aerospace or pharmaceutical conglomerates.1 This structural protection is coupled with a $250,000 per-applicant ceiling, ensuring that no single firm—even within the small business pool—can exhaust the available funds.8

Defining the “Small Business” Participant: The Net Book Value Metric

Eligibility for the $3.5 million set-aside is governed by a precise financial definition rather than traditional headcount or revenue metrics used in other state programs. Under Tax-General § 10-721(a)(8), a “small business” is a for-profit entity with net book value assets totaling less than $5 million.9

The Asset Test Methodology

The “net book value assets” calculation is a rigorous balance-sheet exercise. It is defined as the total value of all assets, including intangible assets, as reported on the balance sheet, less the accumulated depreciation and amortization.8 Crucially, liabilities are not deducted from this figure; the test measures the book value of the company’s infrastructure and intellectual property, not its equity or net worth.8

The timing of this assessment offers a significant advantage to rapidly scaling startups. A business qualifies for the small business set-aside if it meets the $5 million threshold at either the beginning or the end of the taxable year in which the Maryland qualified R&D expenses were incurred.8 This provision allows a company that receives a large venture capital infusion mid-year (which might be used to purchase equipment that pushes assets over $5 million by year-end) to still qualify based on its beginning-of-year financial status.8

Implications of Asset Valuation

The inclusion of intangible assets at book value is particularly relevant for biotechnology and software firms.8 While a company may have intellectual property with a market valuation in the hundreds of millions, its “book value” is often much lower, consisting primarily of the costs capitalized for filing patents or acquiring licenses.1 This accounting distinction allows high-value technology firms to remain within the small business pool longer than they would under a market-cap or revenue-based definition.

The Mechanics of the Fiscal Cap: Allocation and Reciprocal Overflow

The “Portion of Cap” terminology used in Department of Commerce guidance refers to the administrative partitioning of the $12 million annual legislative appropriation into two distinct funding buckets.8 This partitioning is not merely a target but a statutory mandate with built-in flexibility for undersubscribed years.

The Bifurcated Funding Model

The $3.5 million set-aside represents nearly 30% of the total program funding, a significant increase in the proportional support available to smaller firms compared to the pre-2021 era.1 However, the law recognizes that application volumes may fluctuate. To prevent state funds from going unused, Tax-General § 10-721(c)(5) establishes a “reciprocal increase” or overflow mechanism.9

If the total credits applied for by small businesses are less than $3.5 million in a given calendar year, the remaining difference is automatically transferred to increase the $8.5 million pool available for non-small businesses.9 Conversely, if the non-small business pool is undersubscribed (less than $8.5 million in applications), the surplus is added to the small business set-aside.9 In the current economic climate, both pools are typically oversubscribed, making these overflow provisions a secondary safeguard rather than a regular occurrence.3

Refundability: The Critical Advantage for Early-Stage Liquidity

Perhaps the most compelling reason for a business to seek qualification under the set-aside is the privilege of “Refundability.” For many R&D-intensive companies, especially those in the pharmaceutical or deep-tech sectors, the early years of operation are characterized by significant spending on research with little to no state income tax liability.1

Cash Conversion of Tax Assets

While larger corporations must carry forward their unused R&D credits to future tax years (up to 7 years), small businesses certified after December 15, 2012, are entitled to a full refund of any credit amount that exceeds their tax liability.8 If a small business is awarded a $50,000 credit but only owes $2,000 in Maryland income tax, the Comptroller of Maryland will issue a refund check for the $48,000 difference.14

This mechanism effectively transforms the R&D credit from a deferred tax asset into immediate working capital.1 For a startup, this refund can be reinvested into payroll for additional engineers, the purchase of laboratory supplies, or the expansion of patent filings, creating a virtuous cycle of innovation and funding that is not available to larger, more established peers.1

Maryland Base Amount: The Incremental Incentive Model

The Maryland R&D credit is not a flat subsidy on total spending; it is an “incremental” credit designed to incentivize businesses to increase their research investments over time.11 This is achieved by applying the 10% credit rate only to the amount of Maryland qualified research expenses (QREs) that exceed a firm’s “Maryland Base Amount”.11

Calculating the Base Amount

The calculation of the base amount involves a complex interaction between historical QREs and historical Maryland gross receipts. The Maryland Department of Commerce defines the “Maryland Base Amount” by referencing the federal base amount definition in IRC § 41(c), but with state-specific substitutions.9

The process follows these mathematical steps:

1. Fixed-Base Percentage: The sum of Maryland QREs for the four taxable years preceding the credit year is divided by the sum of Maryland gross receipts for those same four years.8
2. Average Annual Gross Receipts: The average of the Maryland gross receipts for the preceding four years is calculated.8
3. Base Amount Calculation: The fixed-base percentage is multiplied by the average annual gross receipts.11

For startups and firms that have not previously conducted research in Maryland, the law provides a “startup base” of zero.8 This allows a first-year research firm to claim the 10% credit on the entirety of its Maryland QREs, a significant windfall that provides maximum support during the most vulnerable stage of a company’s lifecycle.8

Mathematical Scenario for an Establishing Firm

In this scenario:

• Fixed-Base % = $700,000 / $5,700,000 ≈ 12.28%
• Maryland Base Amount = 12.28% × $1,425,000 = $174,990
• If the current year QREs are $500,000, the credit is calculated on $325,010 ($500,000 – $174,990).8

Proration and the Real-World Effective Rate

The “10%” rate cited in promotional materials is the statutory maximum, but in practice, the effective rate for a small business is often lower due to the popularity of the program.3 If the total credits applied for within the small business pool exceed the $3.5 million set-aside, the Department of Commerce must prorate the awards.9

The Proration Formula for Small Businesses

The approved credit for a small business applicant is determined by multiplying their potential credit by a fraction:

• Numerator: $3,500,000 9
• Denominator: Total of all credits applied for by all small businesses in that calendar year 9

In years of high participation, such as 2019, the demand for credits far exceeded the available caps.3 While the 2021 overhaul consolidated more funds into the Growth credit, the “subscription risk” remains a critical factor for tax planning.1 For example, if small businesses collectively apply for $7 million in credits, each individual applicant will only be certified for 50% of their calculated amount.9

The elimination of the 3% Basic credit was specifically intended to focus resources on the Growth model, thereby increasing the “effective rate” for those firms that are actually expanding their R&D footprint in Maryland.1

Administrative Guidance: The Two-Step Certification and Claim Process

The Maryland R&D tax credit is not an “automatic” credit claimed directly on a tax return. It involves a rigorous pre-certification process through the Maryland Department of Commerce followed by a formal filing with the Comptroller of Maryland.8

Step 1: Application to the Department of Commerce (Deadline: Nov 15)

By November 15 of the calendar year following the tax year in which the expenses were incurred, businesses must submit an online application.8 For a business operating on a 2024 calendar year, the application for 2024 expenses must be submitted by November 15, 2025.11

The application requires detailed substantiation, including:

• A narrative description of research activities meeting the four-part test.15
• Documentation of Maryland gross receipts for the prior four years.11
• Payroll data for employees engaged in research within the state.8
• For small businesses, a balance sheet proving net book value assets are under $5 million.8
• Proof of “Good Standing” with the State Department of Assessments and Taxation (SDAT).14

Step 2: Certification and Filing with the Comptroller (Deadline: Feb 15)

By February 15 of the year following the application (e.g., February 15, 2026, for 2024 expenses), the Department of Commerce issues a certification letter.8 This letter specifies the exact amount of the credit that the business is authorized to claim.8

To utilize the credit, the business must then:

1. File an Amended Return: Because the certification happens after the original tax year has closed, businesses typically file an amended Maryland income tax return for the year the expenses were incurred.2
2. Form 500CR: The credit is claimed using Maryland Form 500CR, which must be filed electronically.19 Small businesses claiming a refund must ensure the “refundable” boxes are correctly checked in Part B of the form.14

Failure to attach the Department of Commerce certification letter to the tax return will result in an immediate disallowance of the credit by the Comptroller’s office.8

Compliance and Audit Readiness: The Four-Part Test in Maryland

Maryland adheres to the federal definition of “qualified research” as defined in IRC § 41(d).11 For a business to qualify for the small business set-aside, its activities must satisfy the “Four-Part Test,” which serves as the standard for both state and federal audits.16

1. Technological in Nature

The research must rely on the principles of hard sciences, such as engineering, biology, chemistry, computer science, or physics.16 Maryland’s guidance excludes activities rooted in the social sciences, arts, or humanities.15 In the context of Maryland’s economy, this often applies to the design of new medical devices in the Baltimore-Washington corridor or the development of novel software algorithms for cybersecurity firms in Fort Meade.21

2. Permitted Purpose

The activity must be intended to improve the functionality, performance, reliability, or quality of a “business component”—defined as a product, process, software, technique, formula, or invention held for sale or use in the taxpayer’s trade.15 Ordinary aesthetic changes or cosmetic improvements do not qualify.15

3. Elimination of Uncertainty

The taxpayer must intend to discover information that would eliminate uncertainty concerning the capability, method, or appropriate design of a business component.16 Uncertainty exists if the information available to the taxpayer does not establish whether the component can be developed or how it should be designed to achieve its technical objectives.15

4. Process of Experimentation

Substantially all of the activities must constitute a process of experimentation.16 This involves the identification of a technical objective, the evaluation of alternatives, and the use of a systematic method (such as modeling, simulation, or trial-and-error) to arrive at the final design.15 Documentation of “failed” experiments is often the strongest evidence of a legitimate process of experimentation during an audit.15

Qualified Research Expenses (QREs) and Location Requirements

The credit is only available for expenses “incurred in the state”.8 This geographic nexus is strictly enforced by the Department of Commerce and the Comptroller.

Wage Expenses

The primary component of most R&D claims is “qualified wages” paid to employees directly involved in research or those directly supervising or supporting it.15 To qualify for the Maryland credit, the employee’s services must be performed in Maryland.2 This becomes a nuanced issue for firms with remote workforces; if an engineer lives and works in Virginia for a Maryland-based firm, their wages are generally ineligible for the Maryland R&D credit, though they may qualify for the federal credit.2

Supply Expenses

Supplies used in the conduct of qualified research are eligible, provided they are not depreciable property.15 For a small business biotech startup, this includes lab reagents, chemicals, and prototype materials consumed during the testing phase.15

Contract Research Expenses

If a small business hires a third party (such as a Maryland-based university or a contract research organization) to perform research on its behalf, 65% of those expenses can typically be included as QREs.15 However, the taxpayer must maintain “substantial rights” to the research and bear the “financial risk”—meaning the payment must not be contingent on the success of the research.8

Documentation Strategies for Small Businesses

Because small businesses are often subject to the highest level of scrutiny due to the refundability feature, meticulous record-keeping is essential.8 Revenue office guidance emphasizes that contemporary records are far superior to post-hoc reconstructions.15

Recommended documentation includes:

• Time Tracking: Detailed logs showing the percentage of time each employee spent on specific R&D projects.15
• Innovation Logs: Project notes, white papers, and design meeting minutes that document the technical challenges faced and the alternatives evaluated.15
• Financial Records: General ledger detail showing the separation of R&D expenses from general administrative costs.8
• Federal Form 6765: While not a strict requirement for applying, aligning the state claim with the federal R&D tax credit filing (Form 6765) adds significant credibility to the state application.15

Sector-Specific Analysis: Who Benefits Most from the Set-Aside?

The $3.5 million set-aside is strategically utilized by several key industries that define Maryland’s modern economy. The “portion of cap” designated for small businesses is frequently exhausted by firms in these high-growth sectors.3

Biotechnology and Life Sciences

Maryland is home to one of the nation’s premier bio-health clusters. Small biotech firms often have massive R&D spends relative to their physical assets, making them the primary beneficiaries of the set-aside.6 Because these firms are often pre-revenue, the refundability feature of the small business credit is their most important source of non-dilutive funding.1

Cybersecurity and Software Development

With the presence of the NSA and US Cyber Command, Maryland has a high density of small cybersecurity firms. These companies utilize the credit to offset the high wages of specialized software engineers.21 For software firms, the “internal use software” rules in the federal tax code are complex, but Maryland’s adoption of the federal standard provides a predictable framework for these developers.11

Aerospace and Defense

Small subcontractors for NASA Goddard or the Department of Defense often engage in high-level prototyping and systems integration.21 The R&D credit supports the development of new materials and manufacturing techniques that allow these small firms to compete for federal contracts.21

Comparative Analysis: Maryland vs. Other Jurisdictions

To fully appreciate the meaning of the Maryland Small Business Set-Aside, it is useful to compare it to the federal R&D credit and other state-level incentives.

Maryland’s program is more restrictive due to its annual cap, but it is more aggressive in its refundability.1 While the federal government allows “qualified small businesses” to use the credit to offset up to $500,000 in payroll taxes (effective for tax years after 2022), Maryland provides a direct income tax refund regardless of payroll tax liability.1

Case Study: BioSense Maryland, LLC

To illustrate how the Small Business Set-Aside applies in a complex legal and fiscal context, consider the hypothetical case of BioSense Maryland, LLC, a medical device startup based in Baltimore.

Financial Profile (Tax Year 2024)

• Beginning-of-Year Assets: $3,500,000
• End-of-Year Assets: $5,500,000 (after a mid-year funding round)
• 2024 Maryland QREs: $800,000
• Maryland Base Amount: $200,000
• 2024 Maryland Tax Liability: $4,000

Step 1: Qualification and Application

BioSense qualifies for the Small Business Set-Aside because its beginning-of-year assets were under $5 million, even though its end-of-year assets exceeded the threshold.8 The company submits its application to the Department of Commerce by November 15, 2025.11

Step 2: Calculation and Proration

The potential credit is 10% of the growth over the base amount:

• $(\$800,000 – \$200,000) \times 10\% = \$60,000$

Assume that the small business pool is oversubscribed by 25% that year (meaning total applications are $4.375 million for a $3.5 million pool).9

• Proration Factor = $3.5M / $4.375M = 0.80$
• Certified Credit = $\$60,000 \times 0.80 = \$48,000$

Step 3: Claiming the Refund

BioSense receives its certification letter in February 2026.8 It files an amended 2024 Maryland return using Form 500CR.19

• The $4,000 tax liability is offset entirely by the credit.
• The remaining $44,000 is issued as a cash refund.14

This $44,000 refund represents a “meaningful benefit” as envisioned by the authors of SB 196, providing BioSense with the liquidity to hire a new junior researcher or purchase lab equipment without diluting the founders’ equity.1

Future Outlook: The Income Tax Benefit Transfer Program

A recent development in Maryland’s fiscal policy is the proposed “Income Tax Benefit Transfer Program” (HB 35), which could further enhance the value of R&D credits for small technology companies.12 This program would allow eligible technology companies with unused R&D tax credits to “transfer” or sell those credits to other unaffiliated taxpayers in the state in exchange for cash.12

While the small business set-aside already provides refundability, this transfer program would provide an alternative liquidity path for companies that may not meet the “net book value” definition of a small business but still possess significant unused carryforward credits.12 This highlights Maryland’s ongoing commitment to evolving its tax code to support the innovation economy.1

Common Pitfalls for Small Business Applicants

Despite the robust benefits, several common errors can lead to the denial of small business status or the reduction of certified credits.

1. Improper Asset Valuation: Firms often fail to include intangible assets or fail to properly account for accumulated depreciation, leading to an incorrect “net book value” calculation that may inadvertently disqualify them from the set-aside.8
2. Missing the Deadline: The November 15 deadline is statutory and absolute; there are no provisions for “late filings” or extensions, even if the taxpayer has an extension for their federal return.8
3. Good Standing Failures: Applications are often rejected because the business is not in “Good Standing” with the SDAT, usually due to a missing Annual Report or unpaid filing fee.14
4. Contract Research Oversights: Small businesses often include 100% of their contractor costs instead of the 65% statutory limit, or they fail to provide the necessary vendor documentation to prove the research was conducted in Maryland.15

Strategic Coordination with the Department of Commerce

For businesses navigating this landscape, engaging with the Maryland Department of Commerce specialists is highly recommended. Administrative guidance emphasizes that the program is oversubscribed and competitive.3 Companies should:

• Apply early to avoid last-minute portal technical issues.8
• Maintain a clear “audit trail” that links every dollar of the claim to a specific technological challenge being addressed in Maryland.8
• Consult with tax advisors who specialize in state-level R&D credits, as the interaction between federal capitalization rules (Section 174) and state-level incentives is increasingly complex.6

Conclusion: The Set-Aside as an Economic Catalyst

The Small Business Set-Aside (Portion of Cap) in the Maryland Research and Development Tax Credit is more than just an accounting partition; it is a fundamental policy statement. By protecting $3.5$ million in annual funding for the state’s smallest innovators, Maryland has created a resilient environment where “pre-revenue” ideas can survive the long journey toward commercialization.

The transition from the old 3%/10% model to the unified Growth model with a dedicated set-aside has successfully addressed the “one-dollar credit” problem, ensuring that the state’s investment in innovation is concentrated where it can do the most good—in the hands of agile, high-growth startups.1 For the small business owner, the credit offers a rare opportunity to convert technical risk into fiscal reward, providing a critical cash buffer that sustains the next generation of Maryland’s economic leaders. As the program enters its final years before the 2027 sunset, the set-aside remains the gold standard for state-level innovation incentives, balancing the needs of industrial giants with the vital survival of the startup ecosystem.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/